Status: Available
Expanded Access to Mepsevii
Individual patient expanded access requests may be considered for patients who have no other treatment options
Trial details
Biological sex: AllType: Expanded AccessSponsor: Ultragenyx Pharmaceutical IncUpdated: Jul 30, 2026
Eligibility criteria
Not listed